The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: FTSE 100 nears one-month high

Tue, 10th Sep 2013 11:39

Receding fears about a potential US military strike on Syria and decent data from China lifted UK stocks on Thursday morning, with the FTSE 100 rising to levels not seen in nearly a month.London's benchmark index was up 0.8% at 6,581.91 by midday; the last time it closed higher was on August 14th when it ended the day at 6,587.43.Russian Foreign Minister Sergei Lavrov yesterday urged Syria to place any chemical weapons they may have under international control in an attempt to avoid action from the States. The news that Syrian counterpart Walid Muallem apparently welcomed the proposal eased concerns over a possible Western intervention this morning, especially given that President Barack Obama said that he would put air strikes on hold if Bashar al-Assad's government follows the initiative."Stocks rallied on the back of this, as investors don't want another war on their hands, and this recommendation from the Russians could sidestep military intervention while saving face," said Market Analyst David Madden from IG.Supporting stocks further was a continuing improvement in economic data from China with the third-quarter outlook for the Asian powerhouse continuing to brighten. Industrial output, fixed-asset investment and retail sales strengthened during the month of August, with all three economic indicators rising by more than expected.Market Strategist Ishaq Siddiqi from ETX Capital said that this morning's data "indicat[es] the world's second-largest economy is finally back above its knees after a turbulent first half of 2013.""China's policymakers are attempting to transform the country's economy into one based on consumption over the current model based on spending and the macro indicators are suggesting that these measures are starting to bear fruit," he said.FTSE 100: Airlines IAG and easyJet flying highAirline groups IAG and easyJet were flying higher this morning as crude continued to pull back from its recent highs as fears over turmoil in the Middle East ease. Elevated oil prices have pressured both stocks over the last few weeks on concerns over the knock-on effects to jet fuel costs. Shares in easyJet were also helped by comments from Chief Executive Carolyn McCall who said in an interview that the company will be "Europe's preferred airline in five years' time" due to its low-cost operating model.Financials were also performing well today with RBS, Standard Chartered, Aviva, Aberdeen Asset Management and Schroders among the highest risers.Leading the downside was pharma giant GlaxoSmithKline which fell sharply after US regulators set out requirements for generic versions of its lung drug Advair, sparking competition concerns over when patents run out in a few years' time.Costa and Premier Inn owner Whitbread was also down after seeing sales growth slow from 13.8% in the first quarter to just 10.8% in the second as the hot summer weather hit demand at its coffee shops.Miners were putting in a mixed performance as increased risk appetite was offset by falling metals prices across the board. Glencore Xstrata was in demand after lifting its synergy target - following its merger - to at least $2bn next year as the miner vowed to cut costs and improve operational efficiency. Precious metals groups Fresnillo and Randgold, however, were out of favour. Rolls-Royce gained after scoring a $175m contract with Asia Gas Pipeline (AGP) for services on a natural gas pipeline in Kazakhstan.Broker comments were also moving a number of blue-chip stocks this morning: Drinks giant SABMiller was on the climb this morning after HSBC upgraded the stock to 'overweight'; consumer products group Unilever was lifted by Deutsche Bank to 'buy'; and Babcock was higher after JPMorgan labelled the engineering support services company as its top pick in the sector.FTSE 250: Ashmore jumps, Oxford Instruments slumpsRecord subscriptions helped emerging markets asset manager Ashmore to drive strong net inflows into its funds in the year to June, giving the share price a boost this morning. Strong net inflows of $13.4bn led to a 22% increase in assets under management (AuM) to $77.4bn during the year, with average AuM rising 13%.Oxford Instruments was a heavy faller after saying that while growth in the order intake rate in Industrial Products and third party Service is encouraging, slowness in R&D markets in the Western economies means that the year is likely to be more second half-weighted.FTSE 100 - RiserseasyJet (EZJ) 1,335.00p +5.37%International Consolidated Airlines Group SA (CDI) (IAG) 319.50p +4.58%Standard Chartered (STAN) 1,502.00p +3.19%Royal Bank of Scotland Group (RBS) 350.80p +3.18%Aviva (AV.) 412.10p +3.08%Aberdeen Asset Management (ADN) 380.40p +3.03%British Land Co (BLND) 574.00p +2.96%Glencore Xstrata (GLEN) 330.10p +2.74%Schroders (SDR) 2,486.00p +2.64%Marks & Spencer Group (MKS) 513.00p +2.50%FTSE 100 - FallersGlaxoSmithKline (GSK) 1,590.00p -3.05%Whitbread (WTB) 3,129.00p -2.71%Fresnillo (FRES) 1,249.00p -1.58%Eurasian Natural Resources Corp. (ENRC) 222.60p -0.98%Randgold Resources Ltd. (RRS) 4,869.00p -0.92%Vodafone Group (VOD) 209.00p -0.67%BG Group (BG.) 1,213.00p -0.33%Bunzl (BNZL) 1,353.00p -0.29%BP (BP.) 443.00p -0.25%Vedanta Resources (VED) 1,189.00p -0.08%FTSE 250 - RisersOcado Group (OCDO) 374.20p +6.91%Ashmore Group (ASHM) 387.60p +6.81%Fenner (FENR) 390.40p +5.26%Thomas Cook Group (TCG) 157.50p +5.07%Inchcape (INCH) 641.00p +4.74%Ferrexpo (FXPO) 186.60p +4.42%Laird (LRD) 233.30p +4.34%Galliford Try (GFRD) 1,066.00p +4.20%Berendsen (BRSN) 940.50p +3.75%Betfair Group (BET) 1,050.00p +3.55%FTSE 250 - FallersOxford Instruments (OXIG) 1,423.00p -5.76%African Barrick Gold (ABG) 175.00p -4.68%Rank Group (RNK) 155.00p -2.58%PayPoint (PAY) 1,086.00p -1.63%Moneysupermarket.com Group (MONY) 170.00p -1.33%BH Macro Ltd. EUR Shares (BHME) € 20.78 -1.28%Telecom Plus (TEP) 1,337.00p -1.26%Telecity Group (TCY) 836.50p -1.18%BH Macro Ltd. GBP Shares (BHMG) 2,140.00p -1.02%BH Global Ltd. GBP Shares (BHGG) 1,181.00p -1.01%BC
More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.